158 related articles for article (PubMed ID: 2998656)
1. Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.
Poli G; Bottazzi B; Acero R; Bersani L; Rossi V; Introna M; Lazzarin A; Galli M; Mantovani A
Clin Exp Immunol; 1985 Oct; 62(1):136-42. PubMed ID: 2998656
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.
Poli G; Introna M; Zanaboni F; Peri G; Carbonari M; Aiuti F; Lazzarin A; Moroni M; Mantovani A
Clin Exp Immunol; 1985 Oct; 62(1):128-35. PubMed ID: 2415279
[TBL] [Abstract][Full Text] [Related]
3. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome.
Lazzarin A; Uberti Foppa C; Galli M; Mantovani A; Poli G; Franzetti F; Nóvati R
Clin Exp Immunol; 1986 Jul; 65(1):105-11. PubMed ID: 3791696
[TBL] [Abstract][Full Text] [Related]
4. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
Smith PD; Ohura K; Masur H; Lane HC; Fauci AS; Wahl SM
J Clin Invest; 1984 Dec; 74(6):2121-8. PubMed ID: 6511917
[TBL] [Abstract][Full Text] [Related]
5. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.
De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R
Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880
[TBL] [Abstract][Full Text] [Related]
6. Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing.
Komiyama A; Ichikawa M; Kanda H; Aoyama K; Yasui K; Yamazaki M; Kawai H; Miyagawa Y; Akabane T
Clin Exp Immunol; 1988 Sep; 73(3):500-4. PubMed ID: 3264774
[TBL] [Abstract][Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
8. [Clinical aspects and observations on patients with lymphadenopathy syndrome].
Helm EB; Bergmann L; Elbert M; Mitrou P; Stille W
Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1955-62. PubMed ID: 6548958
[TBL] [Abstract][Full Text] [Related]
9. Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system.
Prince HE; Moody DJ; Shubin BI; Fahey JL
J Clin Immunol; 1985 Jan; 5(1):21-5. PubMed ID: 3872310
[TBL] [Abstract][Full Text] [Related]
10. Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
Gluckman JC; Klatzmann D; Cavaille-Coll M; Brisson E; Messiah A; Lachiver D; Rozenbaum W
Clin Exp Immunol; 1985 Apr; 60(1):8-16. PubMed ID: 3924452
[TBL] [Abstract][Full Text] [Related]
11. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes.
Prince HE; Kermani-Arab V; Fahey JL
J Immunol; 1984 Sep; 133(3):1313-7. PubMed ID: 6235286
[TBL] [Abstract][Full Text] [Related]
12. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
13. Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes.
Rich EA; Toossi Z; Fujiwara H; Hanigosky R; Lederman MM; Ellner JJ
J Lab Clin Med; 1988 Aug; 112(2):174-81. PubMed ID: 3260932
[TBL] [Abstract][Full Text] [Related]
14. Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome.
Euler HH; Kern P; Löffler H; Dietrich M
Clin Exp Immunol; 1985 Feb; 59(2):267-75. PubMed ID: 3156700
[TBL] [Abstract][Full Text] [Related]
15. Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2.
Delemarre FG; Stevenhagen A; Kroon FP; van Eer MY; Meenhorst PL; van Furth R
AIDS; 1995 May; 9(5):441-5. PubMed ID: 7639969
[TBL] [Abstract][Full Text] [Related]
16. Thymostimulin administration modulates polymorph metabolic pathway in patients with chronic obstructive pulmonary disease.
Tortorella C; Ottolenghi A; Moretti AM; Jirillo E; Antonaci S
Immunopharmacol Immunotoxicol; 1992; 14(3):421-37. PubMed ID: 1325490
[TBL] [Abstract][Full Text] [Related]
17. Microbicidal activity of monocyte derived macrophages in AIDS and related disorders.
Eales LJ; Moshtael O; Pinching AJ
Clin Exp Immunol; 1987 Feb; 67(2):227-35. PubMed ID: 3111759
[TBL] [Abstract][Full Text] [Related]
18. Altered monocyte functions in patients with angioimmunoblastic lymphadenopathy.
Pálóczi K; Zeher M; Lukács K; Kávai M; Szegedi G
Haematologia (Budap); 1987; 20(2):109-15. PubMed ID: 3653789
[TBL] [Abstract][Full Text] [Related]
19. Altered functions of peripheral blood monocytes in homosexual males and intravenous drug users with persistent generalized lymphadenopathy.
Roux-Lombard P; Aladjem D; Balavoine JF; Chofflon M; Despont JP; Hirschel B; Jeannet M; Kapanci Y; Lang R; Toccanier MF
Eur J Clin Invest; 1986 Jun; 16(3):262-70. PubMed ID: 3015636
[TBL] [Abstract][Full Text] [Related]
20. Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns.
Friedland GH; Harris C; Butkus-Small C; Shine D; Moll B; Darrow W; Klein RS
Arch Intern Med; 1985 Aug; 145(8):1413-7. PubMed ID: 3875327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
